| |
| |
|
| Insider
Information: |
Malik Fady Ibraham |
| Relationship: |
EVP Research & Develop... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
120,920 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,364,020 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
120,920 |
|
|
| Total
Value |
$6,364,020 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -426.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytokinetics Inc |
CYTK |
EVP Research & Develop... |
2024-09-17 |
120,920 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
132 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-07-23 |
4 |
OE |
$7.96 |
$42,188 |
D/D |
5,300 |
134,304 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-06-11 |
4 |
S |
$53.03 |
$413,106 |
D/D |
(7,788) |
135,004 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-03-06 |
4 |
D |
$39.13 |
$194,007 |
D/D |
(4,958) |
135,183 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-05-07 |
4 |
AS |
$65.11 |
$1,012,265 |
D/D |
(15,547) |
137,056 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-07-09 |
4 |
OE |
$7.96 |
$42,188 |
D/D |
5,300 |
138,304 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-04-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
138,417 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-04-09 |
4 |
S |
$74.31 |
$2,422,918 |
D/D |
(32,605) |
138,567 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-03-05 |
4 |
AS |
$67.53 |
$2,202,606 |
D/D |
(32,604) |
138,973 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-03-01 |
4 |
D |
$19.66 |
$54,399 |
D/D |
(2,767) |
138,982 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-03-02 |
4 |
D |
$39.60 |
$427,086 |
D/D |
(10,785) |
140,141 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-02-26 |
4 |
D |
$18.73 |
$132,234 |
D/D |
(7,060) |
141,749 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
21,333 |
142,567 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-06-11 |
4 |
OE |
$7.96 |
$43,159 |
D/D |
5,422 |
142,792 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-02-06 |
4 |
AS |
$79.28 |
$2,585,497 |
D/D |
(32,605) |
142,973 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-01-04 |
4 |
AS |
$86.98 |
$1,363,712 |
D/D |
(15,678) |
146,973 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2022-03-02 |
4 |
D |
$37.63 |
$188,301 |
D/D |
(5,004) |
148,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-02-11 |
4 |
AS |
$23.34 |
$38,097 |
D/D |
(1,632) |
148,809 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-11-11 |
4 |
AS |
$39.56 |
$79,120 |
D/D |
(2,000) |
148,878 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-12-09 |
4 |
AS |
$36.49 |
$1,064,288 |
D/D |
(29,166) |
149,314 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2020-12-10 |
4 |
AS |
$20.13 |
$21,177 |
D/D |
(1,052) |
150,441 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-01-14 |
4 |
AS |
$19.25 |
$240,619 |
D/D |
(12,500) |
150,441 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-11-09 |
4 |
S |
$35.40 |
$88,500 |
D/D |
(2,500) |
150,664 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-10-14 |
4 |
AS |
$37.73 |
$75,452 |
D/D |
(2,000) |
150,878 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-02-16 |
4 |
D |
$44.13 |
$66,769 |
D/D |
(1,513) |
150,926 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2020-11-12 |
4 |
AS |
$17.15 |
$21,112 |
D/D |
(1,231) |
150,951 |
0 |
- |
|
132 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
